Search results for " Follow-up"

showing 10 items of 229 documents

Disability, Health-Related Quality of Life and Mortality in Lumbar Spine Fusion Patients : A 5-Year Follow-Up and Comparison With a Population Sample

2022

Study Design: Prospective follow-up study. Objectives: We aimed to assess the effect of lumbar spine fusion (LSF) on disability, health-related quality of life and mortality in a 5-year follow-up, and to compare these results with the general population. Methods: 523 consecutive LSF operations were included in a prospective follow-up. Disability was assessed by the Oswestry Disability Index (ODI), and HRQoL by the 36-item Short Form (SF-36) questionnaire using the physical and mental summary scores (PCS and MCS). The patients were compared with an age-, sex-, and residential area matched general population cohort. Results: The preoperative ODI in the patients was 46 (SD 16), and the change …

longer follow-upkuolleisuusselkäsairaudetoutcomepopulation sampleseurantatutkimuselämänlaatulumbar spinal fusion (LSF)mortalityhumanitiesleikkaushoitolanneranka
researchProduct

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease

2006

Abstract Background Sphingomyelin (SM) is the major phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; thus, high levels of SM may promote atherogenesis. Methods We investigated in a median follow up of 6.0 years the association of SM with the incidence of a combined endpoint (myocardial infarction and cardiovascular death) in stable and unstable patients, and its relation to other marker of atherosclerosis in 1,102 patients with angiographically documented CAD and 444 healthy controls. Results and discussion Logistic regression analysis showed that SM categorized by median was associated with an elevated risk for CAD (HR 3.2…

medicine.medical_specialtyAcute coronary syndromeApolipoprotein BEndocrinology Diabetes and MetabolismMedicine (miscellaneous)lcsh:TX341-641Clinical nutritionGastroenterologyCoronary artery diseasechemistry.chemical_compoundMedian follow-upInternal medicinemedicineMyocardial infarctionRisk factorlcsh:RC620-627Nutrition and DieteticsTriglyceridebiologybusiness.industryResearchmedicine.diseaselcsh:Nutritional diseases. Deficiency diseasesEndocrinologychemistrybiology.proteinbusinesslcsh:Nutrition. Foods and food supplyNutrition & Metabolism
researchProduct

Twenty-four-hour blood pressure profile in idiopathic REM sleep behavior disorder

2022

Abstract Study Objectives To determine whether autonomic dysfunction in idiopathic REM sleep behavior disorder (iRBD) affects circadian blood pressure (BP) profile. Methods Twenty-one iRBD (mean age 68.8 ± 6.4, mean age at onset 62.2 ± 9.3), 21 drug-free de novo Parkinson’s disease (PD) and 21 control participants (HCs), comparable for age and sex, underwent 24-h ambulatory BP monitoring. A prospective follow-up study was performed to evaluate the occurrence of neurodegenerative disorders in the iRBD cohort. Results In the iRBD group, nighttime systolic BP (SBP) was higher (124.0 ± 20.0, p = .026), nocturnal BP decrease lower (4.0 ± 8.7% for SBP and 8.7 ± 8.0% for diastolic BP [DBP], p = .0…

medicine.medical_specialtyAmbulatory blood pressureREM sleep behavior disorderDiastoleAge and sexdipping statusABPM; blood pressure; circadian BP profile; dipping status; parasomnias; REM sleep behavior disorderBlood Pressure MonitoringPhysiology (medical)Internal medicineAmbulatoryABPMmedicineHumansparasomniasProspective StudiesABPM; blood pressure; circadian BP profile; dipping status; parasomnias; REM sleep behavior disorder; Aged; Blood Pressure; Blood Pressure Monitoring Ambulatory; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; REM Sleep Behavior DisorderAgedcircadian BP profileCircadian blood pressurebusiness.industryblood pressureBlood Pressure Monitoring AmbulatoryMiddle AgedControl subjectsBlood pressureCohortCardiologySleep behaviorNeurology (clinical)businessFollow-Up StudiesSleep
researchProduct

Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study

2008

Abstract Introduction: Mesenteric venous thrombosis (MVT) is an uncommon but potentially life-threatening disease, accounting for 5–15% of mesenteric ischemic events. Most cases of MVT are either identified at laparotomy or at autopsy, with a mortality rate of approximately 50% in old series. Advances in imaging techniques have facilitated the early diagnosis of MVT and, thus, have contributed to a decrease in mortality in the more recent series. The treatment of MVT involves anticoagulation alone or in combination with surgery. Experts suggest that MVT can safely be managed without surgery if there is no evidence of bowel infarction. However, information on the natural history of MVT and o…

medicine.medical_specialtyBowel infarctionbusiness.industryMortality ratemedicine.medical_treatmentImmunologyCell BiologyHematologymedicine.diseaseBiochemistryThrombosisSurgeryNatural historymedicine.anatomical_structureSplanchnic vein thrombosisMedian follow-upLaparotomymedicineVeinbusinessBlood
researchProduct

Granulocyte–Macrophage Colony-Stimulating Factor in the Therapy of Adults with De Novo Acute Myeloblastic Leukemia: An Update of a Double-Blind Rando…

1997

We investigated whether granulocytemacrophage colony-stimulating factor (GMCSF) given concomitantly with chemotherapy (CT) improves the outcome of adults with de novo acute myeloblastic leukemia (AML) by increasing the efficacy of CT and reducing infections. CT included cytarabine (ara-C) daunorubicin, and etoposide (DAV) for induction and early consolidation therapy and one cycle with high-dose (patients aged ≤50 years) or intermediate-dose ara-C (patients aged >50 years) /daunorubicin for late consolidation therapy. Eighty patients were randomized after DAV 1 to receive either GM-CSF (Escherichia coli, 250 µg/m2 per day, s.c.) or placebo starting 48 h prior to DAV II and the subsequent co…

medicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentPlacebo-controlled studyPlaceboGastroenterologyExact testMedian follow-upInternal medicineCytarabinemedicineAbsolute neutrophil countPhysical therapybusinessEtoposidemedicine.drug
researchProduct

Prognostic implications of circumferential location of distal rectal cancer

2010

Aim  This study evaluated the prognostic importance of circumferential tumour position of mid and low rectal cancers. Method  All uT2, uT3 and uT4 tumours of the middle and lower rectum that underwent total mesorectal excision (TME) with curative intent between 1996 and 2006 were included. The predominant circumferential tumour position (anterior, posterior or circumferential) was defined on preoperative endorectal ultrasound examination (ERUS). The relationships between tumour position and other characteristics and recurrence were explored. Results  Two hundred and five patients with distal rectal cancer were operated on for a uT2-T4 tumour. Median follow up was 49 months. The location of …

medicine.medical_specialtyColorectal cancerbusiness.industrymedicine.medical_treatmentGastroenterologyRectumPerioperativemedicine.diseaseTotal mesorectal excisionSurgerymedicine.anatomical_structureMedian follow-upmedicineStage (cooking)businessNeoadjuvant therapyMesorectalColorectal Disease
researchProduct

Childhood maltreatment and clinical severity of treatment‐resistant depression in a French cohort of outpatients (FACE‐DR): One‐year follow‐up

2020

International audience; Childhood maltreatment is associated with major depressive disorder (MDD). It not only increases the risk of lifetime MDD, but it also aggravates its course. Among depressed patients, 20-30% of them experience treatment-resistance depression (TRD). We aimed to assess the association between childhood maltreatment, severity of depression in a unipolar TRD sample, and patient outcomes after one-year of follow-up. Methods: Patients were recruited for a prospective cohort from the French network of TRD expert centers. Depressive symptom severity was assessed with the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Quick Inventory of Depressive Symptomatology se…

medicine.medical_specialtyDepressive disordersMESH: DepressionPopulationMESH: Depressive Disorder MajorPoison controlChildhood trauma03 medical and health sciences0302 clinical medicineInternal medicineSurveys and QuestionnairesMESH: ChildOutpatientsmedicineHumansChild AbuseProspective StudiesMESH: Surveys and QuestionnaireseducationProspective cohort studyChildChildhood neglecteducation.field_of_studyDepressive Disorder Major[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsMESH: Humansbusiness.industryDepressionAntidepressant responseChildhood abuseCTQ treeMESH: Follow-Up StudiesMESH: Child Abusemedicine.diseaseMESH: Prospective Studies3. Good health030227 psychiatryMESH: OutpatientsPsychiatry and Mental healthClinical PsychologySexual abuse[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthCohortMajor depressive disorderTreatment-resistant depressionbusinessTreatment-resistant depression030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large m…

2020

Abstract Background Aim of this study was to evaluate and compare perioperative outcomes of transperitoneal (TP) and retroperitoneal (TR) approaches in a multi-institutional cohort of minimally invasive partial nephrectomy (MI-PN). Material and methods All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 project) between 01/2013 and 12/2016 were evaluated, collecting the pre-, intra-, and postoperative data. The patients were then stratified according to the surgical approach, TP or RP. A 1:1 propensity score (PS) matching was performed to obtain homogeneous cohorts, considering the age, gender, baseline eGFR, surgical indication, clinical dia…

medicine.medical_specialtyIntraoperative ComplicationUrologymedicine.medical_treatmentOperative TimeSurgical approach030232 urology & nephrologyMinimally invasive partial nephrectomy Renal cell carcinoma Retroperitoneal Surgical approach Transperitoneal.lcsh:RC870-923lcsh:RC254-282NephrectomyArticle03 medical and health sciences0302 clinical medicineRenal cell carcinomamedicineMinimally invasive partial nephrectomy; Renal cell carcinoma; Retroperitoneal; Surgical approach; TransperitonealHumansRetroperitoneal SpaceRetrospective StudiesMinimally invasive partial nephrectomybusiness.industryRenal cell carcinoma; Minimally invasive partial nephrectomy; Transperitoneal; Retroperitoneal; Surgical approachTransperitonealPerioperativeRetroperitoneallcsh:Diseases of the genitourinary system. Urologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseNephrectomyKidney NeoplasmsRenal cell carcinomaSurgerySettore MED/24Treatment Outcome030220 oncology & carcinogenesisPropensity score matchingCohortSurgeryLaparoscopyPositive Surgical MarginMinimally invasive partial nephrectomy; Renal cell carcinoma; Retroperitoneal; Surgical approach; Transperitoneal; Follow-Up Studies; Humans; Nephrectomy; Operative Time; Retroperitoneal Space; Retrospective Studies; Treatment Outcome; Kidney Neoplasms; LaparoscopybusinessAbdominal surgeryFollow-Up StudiesSurgical endoscopy
researchProduct

1088 Minimally-invasive pelvic exenteration: a survival analysis

2021

Minimally-invasive pelvic exenteration: a survival analysis. Introduction/Background* Pelvic exenteration for recurrent and persistent gynecological malignancies is traditionally performed with open approach (OA). Nevertheless, reports on the use of minimally-invasive surgical (MIS) approach to pelvic exenteration have been published with promising results in terms of peri-operative morbidity. However, oncological safety of this approach has been poorly investigated. The aim of the present study was to assess the disease-free survival (DFS) and overall survival (OS) of patients undergoing minimally-invasive pelvic exenteration. Methodology All patients undergoing pelvic exenteration for gyn…

medicine.medical_specialtyMultivariate analysisSurgical approachPelvic exenterationbusiness.industryProportional hazards modelAdjuvant chemotherapymedicine.medical_treatmentSurgeryMedian follow-upMedicinebusinessGrading (tumors)Survival analysisMiscellaneous
researchProduct

Comparison of Allogeneic Stem Cell Transplantation for Transformed Acute Myeloid Leukemia Derived from MDS, CMML or MPN. a Report of the Chronic Mali…

2016

Abstract Introduction Myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) and chronic myelomonocytic leukemia (CMML) can progress to acute myeloid leukemia (transformed AML). The aim of this EBMT registry study was to compare 3 year outcome in patients with transformed AMLwho received allogeneic stem cell transplantation according to the primary disease. Patients and Methods Within the European Society of Blood and Marrow Transplantation (EBMT) registry, we found 4214 patients (female: 39%, male: 61%) with transformed acute myeloid leukemia, who received allogeneic stem cell transplantation between 2000 and 2014. The primary disease was MDS (n=3541), CMML (n=251) or MPN (n=4…

medicine.medical_specialtyUnivariate analysisPediatricsbusiness.industryMyelodysplastic syndromesImmunologyChronic myelomonocytic leukemiaMyeloid leukemiaCell BiologyHematologymedicine.diseaseBiochemistry3. Good healthTransplantation03 medical and health sciences0302 clinical medicineMedian follow-uphemic and lymphatic diseases030220 oncology & carcinogenesisInternal medicineStatistical significancemedicineCumulative incidencebusiness030215 immunologyBlood
researchProduct